2020 CiteScore: 1.0
A. R. Dehpour, PharmD, PhD
We have provided a valid number in the manuscript so the journal office will be able to contact the corresponding author.
A GUIDE FOR AUTHORS
1.1. Editorial policy
Acta Medica Iranica is a free per-review journal and publishes original papers related to all areas of basic and clinical medical sciences. Reviews, Educational, symposia, short communications, and letters to the Editor are also accepted. Case reports are considered if justified by their unique significance. Prior consultation with the editor is recommended before preparing or submitting review articles.
Manuscripts are accepted on condition that they have not been previously published or submitted for publication, and are not going to be sent to other journals. This restriction does not apply to works published in a form of abstracts or summaries. After the article was accepted in Acta Medica Iranica, if author(s) publish the article in another journal, according to our policy, it will be publish again as punishment.
Manuscripts should be submitted online via the Acta Medica Iranica online manuscript submission and review system. At the time of submission, complete contact information (postal/mail address, e-mail address, telephone, mobile (necessary), and fax numbers) for the corresponding author is required. First and last names, e-mail addresses, and institutional affiliations of all coauthors are also required. Manuscripts submitted through the online system should not also be submitted by mail or e-mail. After the manuscript is submitted online, the corresponding author will receive a manuscript number. See Manuscript Preparation and Submission Requirements, and other details in these instructions for additional requirements.
Responsibility lies entirely with the author(s), specially corresponding author, for all statements contained in the paper, including bibliographic references. If any mistake has happened in the published paper by authors, they are not allowed to write to PubMed directly and no erratum article will be printed in journal. So it is better to check article accurately before publishing.
Final decision on an article will be made by Editorial Boards after consideration of reviewers' evaluation.
Manuscripts submitted to the journal are accepted on the understanding that the recommendations of the Declarations of Helsinki and Tokyo, for humans, and the European Committee guidelines for the use of experimental animal have been adhered to. Authors must state in the manuscript that the protocol complies with these guidelines and are approved by their instutional ethics committee. For any investigation involving human subject(s), informed consent must be obtained from the subject(s) and/or their guardian(s) and this must be clearly stated in the paper.
The submitted manuscript should be accompanied by a written statement that the manuscript has not and will not be published or submitted in whole or in part in any other journal. This statement should have the signature of all authors.
1.2. Form of Manuscript
Manuscript should be typewritten with single spacing, and with normal margin.
Authors not fully acquainted with proper English usage should have their manuscripts read by a colleague proficient in English before submission of the manuscript. On their acceptance, manuscripts will, if necessary, be revised for English style and language. Should the change be extensive, the manuscripts will be returned to the authors for retyping. Webster's New International Dictionary or the Oxford English Dictionary should be consulted for spelling. Latin plurals should not be used if the English equivalent has become the accepted form, e.g. formulas not formulae. Use of hyphens, capital letters and numbers written or spelled out (e.g. 6 or six) should be consistent throughout the manuscript. Words at the end of a line should not be hyphenated. Latin words should be italicized (e.g. in vitro, in vivo, i.e., per se, etc.).
Ensure that the letter ‘l' and digit ‘1' (also letter ‘O' and digit ‘0') have been used properly.
Abbreviations are a hindrance for the reader. Use as few abbreviations as far as possible and write out names of compounds, receptors, procedures, etc., in full throughout the text of the manuscript.
2. Organization and style of manuscripts
Authors should consult a current issue of the journal the general manner of presentation. Manuscripts should be written in clear, concise English. Terms that are not generally understood and insider's jargon should be avoided. For writing use “Times New Roman” font by the size of 12.
2.1. Full-length manuscripts and short communications
The manuscript of a short communication (which should not exceed 4 pages in print, i.e. aprox. 2000-2300 words including abstract, legends and references) and a full-length paper should be arranged as follows:
Title page (first page): title (not exceeding 100 characters including space between words); surname(s) of author(s), preceded by one name spelled out in full; name and address of the establishment where the work was done; name, full postal address, telephone, fax number and e-mail address of the author to whom proofs and other correspondence should be sent. Second page: abstract and keywords (indexing terms, normally 4-6 items). The abstract should include: the reason why the experiments were done, a very brief description of the experiments (including species, tissue, procedures, etc.), followed by the main results, and finally, a conclusion giving the relevance of the results to the question asked. The abstract must be completely self-explanatory.The abstract should be between 200 to 250 words (100-150 words for short communications and case reports). No footnotes and subtitles may be used and a reference, if cited, must be given in full.
Third page onward, body of the manuscript, divided in to the following sections: 1. Introduction: The introduction should assume that the reader is knowledgeable in the field and should therefore be as brief as possible. State the purpose of the article and summarize the rationale for the study or, observation. Give only strictly pertinent references and do not include data or coclusion from the work being reported.
2.1.2. Materials and Methods
Describe your selection of the observational or experimental subjects (patients or laboratory animals, including controls) clearly. Identify the age, sex, and other important characteristics of the subjects. The definition and relevance of race and ethinicity are ambiguous. Authors should be particularly careful about using these categories. Identify the methods, apparatus (give the manufacturer's name and address in paprantheses), and procedures in sufficient detail to allow other workers to reproduce the results. Procedures detail that has been published previously should be referred to by citation. When a modified procedure is used, only the author's modifications of the previously published method need to be given in detail. SI units should be used throughout the text. Identify precisely all drugs and chemicals used, including generic names (s), dose (s), and route (s) of administration. Reports of randomized clinical trials should present information on all study elements, including the protocol (study population, interventions or exposures, outcomes, and the rationale for statistical analysis), assignment of interventions major study elements, including the protocol (study population, interventions or exposures, outcomes, and the rationale for statistical analysis), assignment of interventions (methods of randomization, concealment of allocation to treatment groups), and the method of masking (blinding). Authors submitting review manuscripts should include a section describing the methods used for locating, selecting, extracting, and synthesizing data. These methods should also be summarized in the abstract. Reports of experiments involving patients and healthy volunteers must demonstrate the steps taken to obtain consent and to maintain confidentiality. The procedures followed must be in accordance with institutional, regional, international guidelines and conform to accepted ethical standards.
Present your results in logical sequence in the text, tables, and illustrations. Do not repeat in the text all the data in the tables or illustrations; emphasize or summarize only important observations. When possible, quantify findings and present them with appropriate indicators of measurement error or uncertainly (such as confidence intervals). Avoid relying solely on statistical hypothesis testing, such as the use of P-value, which fails to convey important quantitative information.
Report complications of treatment. Give numbers of observations. Report losses to observation (such as dropouts from a clinical trial). Specify the statistical methods used to analyze the data. Restrict tables and figures to those needed to explain the argument of the paper and to assess its support. Use graphs as an alternative to tables with many entries; do not duplicate data in graphs and tables. Avoid non technical uses of technical terms in statistics.
Emphasize the new and important aspects of the study and the conclusions that follow them. Do not repeat in detail data or other material given in the Introduction or the results section. Include in the Discussion section the implications of the findings and their limitations, including implications for further research. Relate the observations to other relevant studies. Link the conclusions with the goals of the study but avoid unqualified statements and conclusions not completely supported by the data. In particular, authors should avoid making statements on economic benefits and costs unless their manuscript includes economic data and analysis. Avoid claiming priority and alluding to work that has not been completed. State new hypotheses when warranted, but clearly label them as such. Recommendations, when appropriate, may be included.
These should be included at the end of the text and not in footnotes. Personal acknowledgements should precede those of institutions or agencies.
References must be numbered consecutively as they are cited. References first cited in a table or figure legend should be numbered so that they will be in sequence with references cited in the text at the point where the table or figure is first mentioned. List all authors when there are six or fewer; when there are seven or more, list the first six, followed by “et al.” The following are sample references.
Only references closely related to the author's work
should be listed and these should be confined to published articles or those accepted for publication and in press. Citation of submitted manuscripts, unpublished data and personal communications should be avoided, but if essential, they should be cited parenthetically in the text (e.g., Tanaka JA., pers. Comm.). In such cases, the authors must obtain permission
from the data owner to quote his or her unpublished
work. Journal abbreviations should conform to those in the
latest edition of PubMed. All authors should be
quoted. Authors are responsible for the accuracy of their references.
Examples of references
1. Shapiro AMJ, Lakey JRT, Ryan EA, Korbutt GS, Toth E, Warnock GL, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000;343:230-8-3.
2. Goadsby PJ. Pathophysiology of headache. In: Silberstein SD, Lipton RB, Dalessio DJ, eds. Wolff's headache and other head pain. 7th ed. Oxford, England: Oxford University Press, 2001:57-72.
3. Kuczmarski RJ, Ogden CL, Grammer-Strawn LM, et al. CDC growth charts: United States. Advance data from vital and health statistics. No. 314. Hyattsville, Md.: National Center for Health Statistics, 2000. (DHHS publication no. (PHS) 2000-1250 0-0431).
4. U.S. positions on selected issues at the third negotiating session of the Framework Convention on Tobacco Control. Washington, D.C.: Committee on Government Reform, 2002. (Accessed March 4, 2002, at http://www.house.gov/reform/min/inves_tobacco/index_accord.htm).
5. 21st Century heart solution may have a sting in the tail. BMJ 2002; 325: 184.
6. Kaplan SJ. Post-hospital home health care: the elderly's access and utilization [dissertation]. St. Louis (MO): Washington Univ., 1995.
7. Kimura J, Shibasaki H, editors. Recent advances in clinical neurophysiology. Proceedings of the International Congress of EMG and Clinical Neurophysiology. 1995 Oct. 150-19, Kyoto, Japan. Amsterdam: Elsevier, 1996.
Tables should be typed in the same page and numbered consecutively with Arabic numerals. Tables should be self-explanatory and include a brief descriptive title. Give each column a short or abbreviated heading. Place explanatory matter in footnotes indicated by lower case letters, not in the heading. Explain in footnotes all nonstandard abbreviations that are used in each table. Footnotes should not include extensive experimental details. Be sure that each table is cited in the text. If you use data from another published or unpublished source, obtain permission and acknowledge them fully.
Figures should be professionally drawn and photographed. Send sharp, glossy, photographic prints. Figures should be inserted in the body of article in own place.Letters, numbers, and symbols should be clear and of sufficient size that when reduced for publication each item will still be legible. Each figure should have a self-adhesive label on its back indicating the number of the figure, author's name, and top of the figure. Human subjects must not be identifiable in photographs, or their pictures must be accompanied by written permission to use the photograph. Figures should be numbered consecutively according to the order in which they have been first cited in the text. The original source of a previously published figure must be acknowledged. Written permission from the
copyright holder is required, except for public documents. Legends for illustrations should be typed using double spacing, starting on a separate page, with Arabic numerals corresponding to the illustrations. Symbols, arrows, numbers, or letters used to identify parts of the illustrations must be identified and explained in the legend.
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.
|All the work in this journal are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.|